Bristol-Myers Squibb, one of the world’s largest pharmaceutical companies, arose out of a 1989 merger and today focuses on the manufacture of prescription medicines for the treatment of cancer, diabetes, cardiovascular disease, and psychiatric disorders. In 2021, the company took part in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, a collaboration with the National Institutes of Health, whose goal was to develop a national strategy for a coordinated COVID-19 research response. As part of the initiative, Bristol-Myers Squibb donated several of its products to trials aimed at assessing potential treatments for patients with COVID-19.
Lists ranking Bristol-Myers Squibb
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
Latest news for Bristol-Myers Squibb
- HealthBooster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earningsAugust 5, 2021 9:32 PM UTC
- TechBritish A.I. drug discovery startup Exscientia buys Austrian cancer cell screening companyJune 15, 2021 8:00 AM UTC
- HealthSeniors face steep drug costs as Congress stalls on capping Medicare out-of-pocketsDecember 28, 2020 10:00 AM UTC
- FinanceWarren Buffett is going all in on the vaccine rally, piling into these stocksNovember 17, 2020 10:55 AM UTC